J

Jumpcode Genomics

30 employees

JUMPCODE's CRISPR-mediated rRNA depletion kits remove nucleic acids from sequencing workflows to improve sensitivity and performance.

Basic info

Industry

biotechnology research

Sectors

infectiousdisease
Biotechnology
biotechnology
Wellness
oncology
research
sequencing
genome
Health Care
dna
genomics
ngs
crispr

Date founded

2016

Funding rounds raised

Total raised

$21M

from 1 investors over 1 rounds

J

Jumpcode Genomics raised $21M on January 20, 2021

Investors: LYZZ CAPITAL

FAQ